Liberty Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,320
Closed -$208K 107
2018
Q3
$208K Sell
2,320
-400
-15% -$35.3K 0.11% 104
2018
Q2
$216K Sell
2,720
-20
-0.7% -$1.66K 0.13% 104
2018
Q1
$244K Sell
2,740
-21,012
-88% -$2.02M 0.15% 97
2017
Q4
$2.52M Sell
23,752
-290
-1% -$32.7K 1.33% 31
2017
Q3
$2.92M Sell
24,042
-582
-2% -$79.3K 1.6% 22
2017
Q2
$3.26M Sell
24,624
-813
-3% -$99.6K 1.97% 13
2017
Q1
$3.17M Sell
25,437
-210
-0.8% -$25.1K 1.9% 12
2016
Q4
$2.96M Sell
25,647
-180
-0.7% -$20K 1.92% 15
2016
Q3
$2.7M Buy
+25,827
New +$2.8M 1.76% 17

Other funds holding CELG

Liberty Capital Management's CELG Position: Q4 2018 in Review

Liberty Capital Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,320 shares — an estimated $208K sold.

Liberty Capital Management first reported a position in CELG in Q3 2016 and held it in 9 quarters. The position peaked at $3.26M in Q2 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Liberty Capital Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Liberty Capital Management sold 2,320 Celgene Corp shares in Q4 2018, an estimated $208K.
  • Liberty Capital Management first reported a position in Celgene Corp in Q3 2016 and held it in 9 quarters.
  • Liberty Capital Management's Celgene Corp position peaked at $3.26M in Q2 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Liberty Capital Management's 13F filing for Q4 2018, filed 24 Jan 2019.